republic-os/legislation/us/states/va/2019/hb-2557.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	Drug Control Act; classifies gabapentin as a Schedule V controlled substance.	Classifies gabapentin as a Schedule V controlled substance. Current law lists gabapentin as a drug of concern. The bill also removes the list of drugs of concern from the Code of Virginia and provides that any wholesale drug distributor licensed and regulated by the Board of Pharmacy and registered with and regulated by the U.S. Drug Enforcement Administration shall have until July 1, 2020, or within six months of final approval of compliance from the Board of Pharmacy and the U.S. Drug Enforcement Administration, whichever is earlier, to comply with storage requirements for Schedule V controlled substances containing gabapentin.	us/states/va	Virginia General Assembly	2019	HB 2557	Virginia HB 2557 (2019)	bill	Narcotics and Drugs Professions and Occupations	enacted	Todd E. Pillion	4	19	6	2019-01-09	2019-03-05	openstates	ocd-bill/4b30923f-961a-471d-bbc1-a292b753b21e	http://lis.virginia.gov/cgi-bin/legp604.exe?191+sum+HB2557	8a02e8b2be8eefe8854a92eb0a19922ec65f2bdcebd3e350ea76810195cf582a	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-va

Virginia HB 2557 (2019) — Drug Control Act; classifies gabapentin as a Schedule V controlled substance.

Classifies gabapentin as a Schedule V controlled substance. Current law lists gabapentin as a drug of concern. The bill also removes the list of drugs of concern from the Code of Virginia and provides that any wholesale drug distributor licensed and regulated by the Board of Pharmacy and registered with and regulated by the U.S. Drug Enforcement Administration shall have until July 1, 2020, or within six months of final approval of compliance from the Board of Pharmacy and the U.S. Drug Enforcement Administration, whichever is earlier, to comply with storage requirements for Schedule V controlled substances containing gabapentin.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. Governor: Acts of Assembly Chapter text (CHAP0214) (committee substitute) — source
2. House: Bill text as passed House and Senate (HB2557ER) (committee substitute) — source
3. House: Prefiled and ordered printed; offered 01/09/19 19101661D (committee substitute) — source
4. Senate: Committee substitute printed 19106567D-S1 (committee substitute) — source

Votes

• Passed Senate with substitute — 40–0 (pass) · upper
• Senate substitute agreed to by House 19106567D-S1 — 97–0 (pass) · lower
• Reported from Health, Welfare and Institutions — 22–0 (pass) · lower
• Constitutional reading dispensed — 40–0 (pass) · upper
• Reported from Education and Health with substitute — 15–0 (pass) · upper
• Read third time and passed House BLOCK VOTE — 99–0 (pass) · lower

Sponsors

• Todd E. Pillion — primary (person)
• Israel D. O'Quinn — cosponsor (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2019-01-09 Prefiled and ordered printed; offered 01/09/19 19101661D introduction
• 2019-01-09 Referred to Committee on Health, Welfare and Institutions referral-committee
• 2019-01-24 Read first time reading-1
• 2019-01-25 Read second time and engrossed reading-2
• 2019-01-28 Read third time and passed House BLOCK VOTE (99-Y 0-N) passage, reading-3
• 2019-01-29 Constitutional reading dispensed
• 2019-01-29 Referred to Committee on Education and Health referral-committee
• 2019-02-11 Read third time reading-3
• 2019-02-11 Reading of substitute waived
• 2019-02-11 Committee substitute agreed to 19106567D-S1
• 2019-02-11 Engrossed by Senate - committee substitute HB2557S1
• 2019-02-13 Placed on Calendar
• 2019-02-13 Senate substitute agreed to by House 19106567D-S1 (97-Y 0-N)
• 2019-02-15 Enrolled
• 2019-02-15 Signed by Speaker
• 2019-02-15 Signed by President
• 2019-02-19 Enrolled Bill communicated to Governor on February 19, 2019
• 2019-02-19 Governor's Action Deadline Midnight, March 26, 2019
• 2019-03-05 Approved by Governor-Chapter 214 (effective 7/1/19) executive-signature

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/4b30923f-961a-471d-bbc1-a292b753b21e. Confidence: reported (aggregated from official Virginia legislature records).